The Scientist‘s TS Digest has published a snapshot article on the work of Dr Oskar Staufer, the MPBC Affiliated Group Leader based at the INM – Leibniz Institute for New Materials.
Danielle Gerhard’s story looks at Oskar’s research, that uses “synthetic biology to study cancer and the tumor immune environment.”
Oskar has recently authored and co-authored several papers including:
- Synthetic Immunology — Building Immunity from the Bottom-Up with Synthetic Cells
Oskar Staufer
Advanced NanoBiomed Research (2024)
https://doi.org/10.1002/anbr.202400037 - Functional Integration of Synthetic Cells into 3D Microfluidic Devices for Artificial Organ-on-Chip Technologies
Niki Hakami, Anna Burgstaller, Ning Gao, Angela Rutz, Stephen Mann, Oskar Staufer
Advanced Healthcare Materials (2024)
https://doi.org/10.1002/adhm.202303334 - Soft Synthetic Cells with Mobile Membrane Ligands for Ex Vivo Expansion of Therapy-Relevant T Cell Phenotypes
Anna Burgstaller, Nils Piernitzki, Nadja Küchler, Marcus Koch, Thomas Kister, Hermann Eichler, Tobias Kraus, Eva C. Schwarz, Michael L. Dustin, Franziska Lautenschläger, Oskar Staufer
Small (2024)
https://doi.org/10.1002/smll.202401844 - From Theory to Therapy: The Advancements of Extracellular Vesicles in Immunotherapy
Nils Piernitzki, Oskar Staufer
Advanced Therapeutics (2023), Volume 7, Issue 3
https://doi.org/10.1002/adtp.202300340